Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.
In the wake of the COVID-19 pandemic, research into infectious diseases remains an integral and growing avenue of clinical research. What benefits can Human Challenge Trials have for clinicians exploring such diseases?